Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1971 Nov;24(8):705–707. doi: 10.1136/jcp.24.8.705

The effect of oxygen on the fibrinolytic enzyme system in vivo

G M Cunningham 1, G Boyd 1, J Windebank 1, F Moran 1, G P McNicol 1
PMCID: PMC477137  PMID: 5130538

Abstract

Arterial hypoxia has been accepted as a potent stimulus to increased fibrinolytic activity in vivo.

This study has shown that significant levels of arterial hypoxaemia induced in healthy volunteers by breathing a hypoxic gas mixture have failed to induce changes in the fibrinolytic enzyme system.

Full text

PDF
705

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonnar J., Davidson J. F., Pidgeon C. F., McNicol G. P., Douglas A. S. Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J. 1969 Jul 19;3(5663):137–140. doi: 10.1136/bmj.3.5663.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CLARKE R. L., ORANDI A., CLIFFTON E. E. Induction of fibrinolysis by venous obstruction. Angiology. 1960 Oct;11:367–370. doi: 10.1177/000331976001100501. [DOI] [PubMed] [Google Scholar]
  4. CLIFFTON E. E., CLARKE R. L., MURPHY J. Studies on fibrinolytic activity with venous occlusion: treatment of thrombophlebitis. Surgery. 1961 Oct;50:644–650. [PubMed] [Google Scholar]
  5. Dubber A. H., McNicol G. P., Uttley D., Douglas A. S. In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor. Br J Haematol. 1968 Jan;14(1):31–49. doi: 10.1111/j.1365-2141.1968.tb01470.x. [DOI] [PubMed] [Google Scholar]
  6. KWAAN H. C., LO R., McFADZEAN J. S. On the lysis of thrombi experimentally produced within veins. Br J Haematol. 1958 Jan;4(1):51–62. doi: 10.1111/j.1365-2141.1958.tb03833.x. [DOI] [PubMed] [Google Scholar]
  7. KWAAN H. C., MCFADZEAN A. J. The inhibition of clot lysis by corticotrophin. Lancet. 1956 Jan 21;270(6908):136–137. doi: 10.1016/s0140-6736(56)91094-7. [DOI] [PubMed] [Google Scholar]
  8. LACK C. H. PROTEOLYTIC ACTIVITY AND CONNECTIVE TISSUE. Br Med Bull. 1964 Sep;20:217–222. doi: 10.1093/oxfordjournals.bmb.a070335. [DOI] [PubMed] [Google Scholar]
  9. Lieberman J., Kellogg F. Hyaline-membrane formation and pulmonary plasminogen-activator activity in various strains of mice. Pediatrics. 1967 Jan;39(1):75–81. [PubMed] [Google Scholar]
  10. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  11. REMMERT L. F., COHEN P. P. Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem. 1949 Nov;181(1):431–448. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES